Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sethu Sankaranarayanan

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Current Topics in Medicinal Chemistry|May 23, 2006
Genetically modified mice models for Alzheimer's diseaseSethu Sankaranarayanan
International Journal of Toxicology|December 6, 2017
Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative DiseasesJanice A Lansita, Kirsten M Mease, Haiyan Qiu, et al.
Journal of Neuroscience Research|March 25, 2011
Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortexGuoxin Wu, Sethu Sankaranarayanan, Sidney H-K Hsieh, et al.
Protein & Cell|August 9, 2011
Pharmacological applications of a novel neoepitope antibody to a modified amyloid precursor protein-derived beta-secretase productGuoxin Wu, Sethu Sankaranarayanan, Donna L Montgomery, et al.
Journal of Neuroscience Methods|January 10, 2012
Cisterna magna cannulated repeated CSF sampling rat model--effects of a gamma-secretase inhibitor on Aβ levelsJennifer S Shapiro, Mark Stiteler, Guoxin Wu, et al.
Molecular Neurodegeneration|August 22, 2018
Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degenerationHaihan Jiao, Matt Rutar, Nilisha Fernando, et al.
Journal of the American Society for Mass Spectrometry|October 4, 2017
Probing Conformational Dynamics of Tau Protein by Hydrogen/Deuterium Exchange Mass SpectrometryRichard Y-C Huang, Roxana E Iacob, Sethu Sankaranarayanan, et al.
Ophthalmology Science|May 1, 2023
Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in GlaucomaYang Sun, David Wirta, Wendy Murahashi, et al.
Psychopharmacology|June 21, 2013
Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer's diseaseAmy Easton, Sethu Sankaranarayanan, An Tanghe, et al.
Cell Reports|December 5, 2019
The Classical Complement Pathway Mediates Microglia-Dependent Remodeling of Spinal Motor Circuits during Development and in SMAAleksandra Vukojicic, Nicolas Delestrée, Emily V Fletcher, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Current Topics in Medicinal Chemistry|May 23, 2006
Genetically modified mice models for Alzheimer's diseaseSethu Sankaranarayanan
International Journal of Toxicology|December 6, 2017
Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative DiseasesJanice A Lansita, Kirsten M Mease, Haiyan Qiu, et al.
Journal of Neuroscience Research|March 25, 2011
Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortexGuoxin Wu, Sethu Sankaranarayanan, Sidney H-K Hsieh, et al.
Protein & Cell|August 9, 2011
Pharmacological applications of a novel neoepitope antibody to a modified amyloid precursor protein-derived beta-secretase productGuoxin Wu, Sethu Sankaranarayanan, Donna L Montgomery, et al.
Journal of Neuroscience Methods|January 10, 2012
Cisterna magna cannulated repeated CSF sampling rat model--effects of a gamma-secretase inhibitor on Aβ levelsJennifer S Shapiro, Mark Stiteler, Guoxin Wu, et al.
Molecular Neurodegeneration|August 22, 2018
Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degenerationHaihan Jiao, Matt Rutar, Nilisha Fernando, et al.
Journal of the American Society for Mass Spectrometry|October 4, 2017
Probing Conformational Dynamics of Tau Protein by Hydrogen/Deuterium Exchange Mass SpectrometryRichard Y-C Huang, Roxana E Iacob, Sethu Sankaranarayanan, et al.
Ophthalmology Science|May 1, 2023
Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in GlaucomaYang Sun, David Wirta, Wendy Murahashi, et al.
Psychopharmacology|June 21, 2013
Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer's diseaseAmy Easton, Sethu Sankaranarayanan, An Tanghe, et al.
Cell Reports|December 5, 2019
The Classical Complement Pathway Mediates Microglia-Dependent Remodeling of Spinal Motor Circuits during Development and in SMAAleksandra Vukojicic, Nicolas Delestrée, Emily V Fletcher, et al.
Pageof 4